rs28494009

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_006073.4(TRDN):​c.1211T>G​(p.Val404Gly) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.149 in 1,533,254 control chromosomes in the GnomAD database, including 18,325 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.16 ( 2175 hom., cov: 32)
Exomes 𝑓: 0.15 ( 16150 hom. )

Consequence

TRDN
NM_006073.4 missense

Scores

2
16

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:7

Conservation

PhyloP100: 0.0250

Publications

19 publications found
Variant links:
Genes affected
TRDN (HGNC:12261): (triadin) This gene encodes an integral membrane protein found in skeletal and cardiac muscle. The encoded protein plays a role in skeletal muscle excitation-contraction coupling as part of the calcium release complex and is required for normal skeletal muscle strength. This protein indirectly links triads and microtubules in skeletal muscle. Mutations in this gene are associated with cardiac arrythmia syndrome and some variants in this gene may be associated with sudden cardiac death. [provided by RefSeq, May 2022]
TRDN Gene-Disease associations (from GenCC):
  • catecholaminergic polymorphic ventricular tachycardia
    Inheritance: AD, AR Classification: DEFINITIVE, SUPPORTIVE Submitted by: Orphanet, ClinGen
  • catecholaminergic polymorphic ventricular tachycardia 5
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), G2P, Genomics England PanelApp
  • familial long QT syndrome
    Inheritance: AR Classification: STRONG Submitted by: G2P
  • long QT syndrome
    Inheritance: AR Classification: STRONG Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0028282404).
BP6
Variant 6-123377874-A-C is Benign according to our data. Variant chr6-123377874-A-C is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 227107.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.21 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
TRDNNM_006073.4 linkc.1211T>G p.Val404Gly missense_variant Exon 17 of 41 ENST00000334268.9 NP_006064.2
TRDNNM_001251987.2 linkc.1214T>G p.Val405Gly missense_variant Exon 17 of 21 NP_001238916.1
TRDNNM_001407315.1 linkc.1154T>G p.Val385Gly missense_variant Exon 16 of 20 NP_001394244.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
TRDNENST00000334268.9 linkc.1211T>G p.Val404Gly missense_variant Exon 17 of 41 1 NM_006073.4 ENSP00000333984.5
TRDNENST00000662930.1 linkc.1214T>G p.Val405Gly missense_variant Exon 17 of 21 ENSP00000499585.1

Frequencies

GnomAD3 genomes
AF:
0.164
AC:
24966
AN:
152002
Hom.:
2175
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.201
Gnomad AMI
AF:
0.238
Gnomad AMR
AF:
0.110
Gnomad ASJ
AF:
0.0806
Gnomad EAS
AF:
0.0785
Gnomad SAS
AF:
0.221
Gnomad FIN
AF:
0.198
Gnomad MID
AF:
0.0696
Gnomad NFE
AF:
0.156
Gnomad OTH
AF:
0.134
GnomAD2 exomes
AF:
0.152
AC:
28782
AN:
188752
AF XY:
0.158
show subpopulations
Gnomad AFR exome
AF:
0.204
Gnomad AMR exome
AF:
0.0829
Gnomad ASJ exome
AF:
0.0821
Gnomad EAS exome
AF:
0.0834
Gnomad FIN exome
AF:
0.197
Gnomad NFE exome
AF:
0.152
Gnomad OTH exome
AF:
0.131
GnomAD4 exome
AF:
0.148
AC:
203831
AN:
1381138
Hom.:
16150
Cov.:
28
AF XY:
0.151
AC XY:
103345
AN XY:
686038
show subpopulations
African (AFR)
AF:
0.195
AC:
6106
AN:
31260
American (AMR)
AF:
0.0839
AC:
3222
AN:
38398
Ashkenazi Jewish (ASJ)
AF:
0.0820
AC:
2063
AN:
25170
East Asian (EAS)
AF:
0.0651
AC:
2471
AN:
37936
South Asian (SAS)
AF:
0.228
AC:
18322
AN:
80252
European-Finnish (FIN)
AF:
0.197
AC:
10006
AN:
50770
Middle Eastern (MID)
AF:
0.0930
AC:
453
AN:
4872
European-Non Finnish (NFE)
AF:
0.145
AC:
153170
AN:
1054996
Other (OTH)
AF:
0.139
AC:
8018
AN:
57484
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.440
Heterozygous variant carriers
0
6980
13960
20939
27919
34899
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
5430
10860
16290
21720
27150
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.164
AC:
24961
AN:
152116
Hom.:
2175
Cov.:
32
AF XY:
0.165
AC XY:
12257
AN XY:
74350
show subpopulations
African (AFR)
AF:
0.201
AC:
8346
AN:
41514
American (AMR)
AF:
0.109
AC:
1671
AN:
15266
Ashkenazi Jewish (ASJ)
AF:
0.0806
AC:
280
AN:
3472
East Asian (EAS)
AF:
0.0779
AC:
404
AN:
5184
South Asian (SAS)
AF:
0.221
AC:
1066
AN:
4824
European-Finnish (FIN)
AF:
0.198
AC:
2096
AN:
10566
Middle Eastern (MID)
AF:
0.0680
AC:
20
AN:
294
European-Non Finnish (NFE)
AF:
0.156
AC:
10580
AN:
67974
Other (OTH)
AF:
0.133
AC:
281
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
1070
2141
3211
4282
5352
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
278
556
834
1112
1390
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.150
Hom.:
3633
Bravo
AF:
0.156
TwinsUK
AF:
0.155
AC:
573
ALSPAC
AF:
0.166
AC:
640
ESP6500AA
AF:
0.189
AC:
671
ESP6500EA
AF:
0.145
AC:
1178
ExAC
AF:
0.137
AC:
15894
Asia WGS
AF:
0.155
AC:
541
AN:
3478

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:7
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:5
Apr 09, 2025
Molecular Diagnostic Laboratory for Inherited Cardiovascular Disease, Montreal Heart Institute
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Apr 10, 2023
Women's Health and Genetics/Laboratory Corporation of America, LabCorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Sep 26, 2016
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

Nov 24, 2014
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Val404Gly in exon 17 of TRDN: This variant is not expected to have clinical sign ificance because it has been identified in 18.9% (671/3550) of African American chromosomes from a broad population by the NHLBI Exome Sequencing Project (http: //evs.gs.washington.edu/EVS; dbSNP rs28494009). -

Catecholaminergic polymorphic ventricular tachycardia 1 Benign:1
Feb 04, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Cardiovascular phenotype Benign:1
Mar 23, 2015
Ambry Genetics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.11
BayesDel_addAF
Benign
-0.70
T
BayesDel_noAF
Benign
-0.64
CADD
Benign
18
DANN
Uncertain
0.99
DEOGEN2
Benign
0.13
T
Eigen
Benign
-1.0
Eigen_PC
Benign
-0.96
FATHMM_MKL
Benign
0.033
N
LIST_S2
Benign
0.27
T
MetaRNN
Benign
0.0028
T
MetaSVM
Benign
-1.0
T
MutationAssessor
Benign
0.55
N
PhyloP100
0.025
PrimateAI
Benign
0.26
T
PROVEAN
Benign
-0.36
N
REVEL
Benign
0.024
Sift
Uncertain
0.0050
D
Sift4G
Benign
0.37
T
Polyphen
0.047
B
Vest4
0.080
ClinPred
0.018
T
GERP RS
-0.35
Varity_R
0.13
gMVP
0.016
Mutation Taster
=99/1
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.040
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs28494009; hg19: chr6-123699019; COSMIC: COSV62116563; API